Atıf Formatları
Efficiency and safety of direct acting antivirals in chronic hepatitis C patients infected with genotype 2 and 3 in Turkey
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

B. KURTARAN Et Al. , "Efficiency and safety of direct acting antivirals in chronic hepatitis C patients infected with genotype 2 and 3 in Turkey," AASLD - TASL CONNECT REGIONAL MEETING , 2019

KURTARAN, B. Et Al. 2019. Efficiency and safety of direct acting antivirals in chronic hepatitis C patients infected with genotype 2 and 3 in Turkey. AASLD - TASL CONNECT REGIONAL MEETING .

KURTARAN, B., SARIGÜL, F., ÇABALAK, M., KAYA, S., SARI, N., KARSEN, H., ... ZERDALİ, E.(2019). Efficiency and safety of direct acting antivirals in chronic hepatitis C patients infected with genotype 2 and 3 in Turkey . AASLD - TASL CONNECT REGIONAL MEETING

KURTARAN, BEHİCE Et Al. "Efficiency and safety of direct acting antivirals in chronic hepatitis C patients infected with genotype 2 and 3 in Turkey," AASLD - TASL CONNECT REGIONAL MEETING, 2019

KURTARAN, BEHİCE Et Al. "Efficiency and safety of direct acting antivirals in chronic hepatitis C patients infected with genotype 2 and 3 in Turkey." AASLD - TASL CONNECT REGIONAL MEETING , 2019

KURTARAN, B. Et Al. (2019) . "Efficiency and safety of direct acting antivirals in chronic hepatitis C patients infected with genotype 2 and 3 in Turkey." AASLD - TASL CONNECT REGIONAL MEETING .

@conferencepaper{conferencepaper, author={BEHİCE KURTARAN Et Al. }, title={Efficiency and safety of direct acting antivirals in chronic hepatitis C patients infected with genotype 2 and 3 in Turkey}, congress name={AASLD - TASL CONNECT REGIONAL MEETING}, city={}, country={}, year={2019}}